Peripheral arterial rather than venous blood is a better source of circulating tumor cells in early lung cancer
- Published on 02/08/2024
- Reading time: 4 min.
Zhen‐dan Wang 1,2, Yi‐fei Feng 3, Yu‐shuo Wang 4, Ying Ma 5, Jiyan Liu 5, Dihua Li 5, Sheng Li 5,6, Guo‐dong Zhang 2
1
Department of Thoracic Surgery
Shandong University Cancer Center
Jinan
China
2
Department of Thoracic Surgery, Shandong Cancer Hospital and Institute
Shandong First Medical University and Shandong Academy of Medical Sciences
Jinan
China
3
School of Clinical and Basic Medicine
Shandong First Medical University
Jinan
China
4
Department of Primary Care and Population Health, Institute of Epidemiology and Public Health
London's Global University
London
UK
5
Shandong Pharmaceutical Research Institute
Jinan
China
6
Shandong First Medical University and Shandong Academy of Medical Sciences
Jinan
China
Abstract
Background Circulating tumor cells (CTCs) play a crucial role in the early diagnosis and prognosis of lung cancer. Identification of a more suitable sample source could be a breakthrough towards enhancing CTC detectability in early‐stage lung cancer. We investigated the differences in detectable CTCs between peripheral arterial and venous blood in early‐ and mid‐stage lung cancer patients undergoing surgery and analyzed the association between clinicopathological...
To continue reading this article in Full-Text...
Peer-Reviewed Journals A-Z
Search | Advanced search
Get the latest news in Oncology
Receive our newsletter to stay up to date with the latest news in Oncology
